Peer-reviewedCC BYFrontiers in immunology
Trained immunity in cancer immunotherapy and vaccine development: mechanisms, evidence gaps, and translational opportunities
- 1Affiliated Hospital of Xiangnan University , , ,
- 2Department of Gynecology and Obstetrics, Renmin Hospital of Wuhan University , ,
- 3Guangzhou Key Laboratory of Formula-Pattern of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Jinan University , ,
Related
- Stem cell factor in allergic diseases: mechanisms of type 2 immunity and therapeutic opportunities
- EEG in Parkinson’s Disease: Mechanisms, Biomarkers and Translational Opportunities
- The Gut Virome in Gastrointestinal Cancers: Mechanisms, Biomarkers, and Translational Opportunities.
- Targeting inhibitory phagocytosis checkpoints in cancer immunotherapy: mechanisms, therapeutic strategies, and translational challenges
- Coronavirus Exploitation of Ubiquitination and Selective Autophagy to Control Innate Immunity: Mechanisms, Systems Logic, and Therapeutic Opportunities.
BibTeX
@article{yang2026trained,
title = {{Trained immunity in cancer immunotherapy and vaccine development: mechanisms, evidence gaps, and translational opportunities}},
author = {Lian Yang and Jianfeng Liu and Shufei Zhang and Yong He and Jiaxu Chen and Donghui Tan},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13655919},
note = {CC BY},
}
RIS
TY - JOUR
TI - Trained immunity in cancer immunotherapy and vaccine development: mechanisms, evidence gaps, and translational opportunities
AU - Lian Yang
AU - Jianfeng Liu
AU - Shufei Zhang
AU - Yong He
AU - Jiaxu Chen
AU - Donghui Tan
PY - 2026
DA - 2026/10/16
JO - Frontiers in immunology
UR - https://europepmc.org/article/PMC/PMC13655919
SN - 1664-3224
ER -